Skip to main content
Equibles

BYAH · Park Ha Biological Technology Co., Ltd. · Metrics

Track BYAH — free

Use BYAH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BYAH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.36 -0.13 (-5.22%) At close · Oct 22
Rebalance outlook locked
Market Cap
$46.05M
Shares
19.51M
Volume · Oct 22 3084 Avg daily vol (55 sessions) 477.98K

BYAH metrics

53 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.36
Market cap
$46.05M

Price action

20 metrics
Price change (1W)
-1.3%
Price change (30D)
-6.3%
Price change (3M)
—
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
—
Annualized volatility (3M)
—
Beta
—
RSI (14D)
46.3
Price vs SMA 50
-8.6%
Price vs SMA 200
—
Avg volume (3M)
477,976
Relative volume
0.0
Average dollar volume
$1.44M

Company

3 metrics
Sector
Consumer Defensive
Industry
Household & Personal Products
Shares outstanding
19.51M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
18.1×
reciprocal yield 5.5%
P / book
8.5
reciprocal yield 11.7%
FCF yield
-1.3%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-11.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
94.9%
Operating margin
-212.2%
Trailing 12 months
Net margin
-214.2%
Gross profit (TTM)
$2.41M
Operating profit (TTM)
−$5.40M
Net income (TTM)
−$5.45M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
-23.0%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$57.88

Growth

11 metrics
Revenue growth YoY
+6.0%
Year over year
Net income growth YoY
-5,191.3%
Revenue (TTM)
$2.54M
Trailing 12 months
EPS growth YoY
-4,410.4%
Shares change YoY
+17.8%
Year over year · more shares
Revenue CAGR (3Y)
+9.6%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-101.1%
Return on assets
-73.0%
Debt / equity
—
Current ratio
3.4
EBITDA (TTM)
−$5.21M
Free cash flow (TTM)
−$584,985
Quick ratio
3.3
Interest coverage
-215,834.0
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$627,851
Total assets
$7.46M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$273,308
Capital expenditures (TTM)
$311,677
R&D (TTM)
$350,715
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
13.8%
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
4
13F filer change QoQ
+1
Institutional ownership
0.0%
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+35,016.0%
Holder tenure
2.9
Price vs estimated holder cost
-30.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.1%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
24 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1986247 CUSIP G6925R128